# Discovery of Alogliptin:  A Potent, Selective, Bioavailable, and Efficacious Inhibitor of Dipeptidyl Peptidase IV

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/discovery-of-alogliptin-a-potent-selective-bioavailable-and-efficacious/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jun Feng,Zhiyuan Zhang,Michael B. Wallace,Jeffrey A. Stafford,Stephen W. Kaldor,Daniel B. Kassel,Marc Navre,Lihong Shi,R.J. Skene,Tomoko Asakawa,Koji Takeuchi,Rongda Xu,David R. Webb,Stephen L. Gwaltney |
| Citations | 406 |
| DOI | 10.1021/jm070104l |
| Fields | Medicine,Neuroscience |
| Open Access | true |
| OA Status | green |
| OA URL | https://doi.org/10.7270/q2tm78c5 |
| OpenAlex ID | https://openalex.org/W2064780710 |
| PMID | 17441705 |
| Type | article |
| Year | 2007 |

## Paper authors

- [David R. Webb](https://scholariq.org/researchers/david-r-webb/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Peptidase Inhibition and Analysis](https://scholariq.org/topics/peptidase-inhibition-and-analysis/)
- [Neuropeptides and Animal Physiology](https://scholariq.org/topics/neuropeptides-and-animal-physiology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.